Envision Healthcare Co. (EVHC) Given Consensus Rating of “Hold” by Brokerages

Envision Healthcare Co. (NYSE:EVHC) has received a consensus rating of “Hold” from the nineteen brokerages that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have given a buy rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $39.82.

A number of research firms have commented on EVHC. Citigroup cut Envision Healthcare from a “buy” rating to a “neutral” rating and set a $31.00 price target on the stock. in a report on Thursday, November 2nd. Mizuho set a $35.00 price target on Envision Healthcare and gave the company a “hold” rating in a report on Wednesday, January 24th. Piper Jaffray Companies began coverage on Envision Healthcare in a report on Wednesday, December 13th. They set a “neutral” rating and a $35.00 price target on the stock. KeyCorp decreased their price target on Envision Healthcare from $67.00 to $37.00 and set an “overweight” rating on the stock in a report on Thursday, November 2nd. Finally, Canaccord Genuity reissued a “buy” rating and set a $32.00 price target (down from $68.00) on shares of Envision Healthcare in a report on Thursday, November 2nd.

Hedge funds have recently modified their holdings of the company. Exane Derivatives bought a new stake in shares of Envision Healthcare in the third quarter worth about $475,000. Stonebridge Capital Management Inc. increased its holdings in shares of Envision Healthcare by 87.0% in the third quarter. Stonebridge Capital Management Inc. now owns 30,329 shares of the company’s stock worth $1,364,000 after purchasing an additional 14,111 shares during the last quarter. Honeywell International Inc. increased its holdings in shares of Envision Healthcare by 17.4% in the third quarter. Honeywell International Inc. now owns 542,100 shares of the company’s stock worth $24,367,000 after purchasing an additional 80,200 shares during the last quarter. Nomura Holdings Inc. bought a new stake in shares of Envision Healthcare in the second quarter worth about $797,000. Finally, CI Investments Inc. bought a new stake in shares of Envision Healthcare in the third quarter worth about $9,084,000.

Shares of Envision Healthcare (EVHC) opened at $36.69 on Tuesday. The company has a current ratio of 3.01, a quick ratio of 3.00 and a debt-to-equity ratio of 0.89. The company has a market capitalization of $4,460.00, a PE ratio of -24.62, a price-to-earnings-growth ratio of 0.95 and a beta of 0.57. Envision Healthcare has a twelve month low of $23.77 and a twelve month high of $73.00.

ILLEGAL ACTIVITY WARNING: “Envision Healthcare Co. (EVHC) Given Consensus Rating of “Hold” by Brokerages” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/02/13/envision-healthcare-co-evhc-given-consensus-rating-of-hold-by-brokerages.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply